Sept 26 (Reuters) - Bionomics Ltd (BNO) :
- BIONOMICS- POSITIVE RESULTS FROM PHARMACOKINETIC STUDY IN HEALTHY VOLUNTEERS USING SOLID DOSE FORMULATION OF CO'S ' LEAD DRUG CANDIDATE, BNC210
- STUDY DEMONSTRATES SOLID DOSE OF BNC210 ACHIEVES BLOOD LEVELS PREDICTED AS NECESSARY TO MEET PRIMARY ENDPOINTS
Source text http//reut.rs/2lgCrI2
(([email protected];))
Add to My Watchlist
What is My Watchlist?